Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
Int J Cardiol
    July 2023
  1. MILLET LM, Ali MJ, Mohandas R
    Practice patterns and clinical outcomes of severe coronary artery disease in dialysis patients.
    Int J Cardiol. 2023;382:1-2.
    >> Share

    June 2023
  2. SCHMITT A, Schupp T, Rusnak J, Ruka M, et al
    Does sex affect the risk of 30-day all-cause mortality in cardiogenic shock?
    Int J Cardiol. 2023;381:105-111.
    >> Share

  3. FUJII T
    Replay to "duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk".
    Int J Cardiol. 2023;381:1.
    >> Share

  4. GUREVITZ C, Assali A, Mohsan J, Gmach SF, et al
    The obesity paradox in patients with acute coronary syndromes over 2 decades - the ACSIS registry 2000-2018.
    Int J Cardiol. 2023;380:48-55.
    >> Share

  5. LOPEZ-PALOP R, Carrillo P, Lozano I
    Non-hyperemic, non pressure wire, coronary physiology. A further step towards the generalization of physiology in the cath-lab?
    Int J Cardiol. 2023;380:1-3.
    >> Share

    May 2023
  6. KLUGER N
    A case of misdiagnosed vasospastic angina in the last of us?
    Int J Cardiol. 2023;379:15.
    >> Share

  7. CROOIJMANS C, Jansen TPJ, Konst RE, Woudstra J, et al
    Design and rationale of the NetherLands registry of invasive Coronary vasomotor Function Testing (NL-CFT).
    Int J Cardiol. 2023;379:1-8.
    >> Share

  8. ZHAO CX, Wei L, Dong JX, He J, et al
    Nomograms referenced by cardiac magnetic resonance in the prediction of cardiac injuries in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2023 May 13:S0167-5273(23)00700.
    >> Share

  9. ZUIN M, di Fusco SA, De Caterina R, Roncon L, et al
    Declining trends of premature mortality from ischemic heart disease and regional differences in Italy from 2011 to 2017.
    Int J Cardiol. 2023 May 8:S0167-5273(23)00649.
    >> Share

  10. XIN A, Li K, Qian G, Chen Y, et al
    Reply to Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 May 5:S0167-5273(23)00653.
    >> Share

  11. LEE WJ, Cheng H, Whitney BM, Nance RM, et al
    Polygenic risk scores point toward potential genetic mechanisms of type 2 myocardial infarction in people with HIV.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00648.
    >> Share

  12. AHMED AI, Al-Mallah MH
    Reply to SPECT and STE: Which one is better in incremental prognostic value over CCTA.
    Int J Cardiol. 2023;378:164-165.
    >> Share

  13. GAUTHIER V, Lafrance M, Barthoulot M, Rousselet L, et al
    Long-term follow-up of survivors of a first acute coronary syndrome: Results from the French MONICA registries from 2009 to 2017.
    Int J Cardiol. 2023;378:138-143.
    >> Share

  14. LANDI A
    Duration more than type of dual antiplatelet therapy matters in ACS patients with high bleeding risk.
    Int J Cardiol. 2023;378:10.
    >> Share

  15. KIMURA S
    Reliability of immature neutrophils in the risk stratification of acute coronary syndrome lesions.
    Int J Cardiol. 2023;378:111-112.
    >> Share

  16. HERMANN R, Mestre Cordero VE, Fernandez Pazos MLM, Reznik FJ, et al
    Role of autophagy in simulated ischemic-reperfused left atrial myocardium.
    Int J Cardiol. 2023;378:77-88.
    >> Share

  17. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
    Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
    Int J Cardiol. 2023;378:105-110.
    >> Share

  18. WANG Z, Yang J, Li C, Huang J, et al
    Dynamic assessment of the left main-left circumflex bending angle: Implications for ostial left circumflex artery in-stent restenosis after successful two-stent PCI.
    Int J Cardiol. 2023;378:11-19.
    >> Share

  19. VAN DE HOEF TP, Boerhout CKM, Piek JJ
    Reply to: "Do we still need to perform FFR and PCI".
    Int J Cardiol. 2023;378:22.
    >> Share

  20. GRAGNANO F, Montalto C, Oreglia JA, Calabro P, et al
    Physiology-guided revascularization of non-culprit lesions in patients with STEMI: Could vFFR be the way?
    Int J Cardiol. 2023;378:20-21.
    >> Share

  21. VARMA Y, Jena NK, Arsene C, Patel K, et al
    Disparities in the management of non-ST-segment elevation myocardial infarction in the United States.
    Int J Cardiol. 2023 May 1:S0167-5273(23)00592.
    >> Share

    April 2023
  22. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
    Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
    Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
    >> Share

  23. FLYGARE O, Boberg J, Ruck C, Hofmann R, et al
    Association of anxiety or depression with risk of recurrent cardiovascular events and death after myocardial infarction: A nationwide registry study.
    Int J Cardiol. 2023 Apr 18:S0167-5273(23)00576.
    >> Share

  24. MORI R, Macaya F, Giacobbe F, Salinas P, et al
    Clinical and angiographic features of SCAD type 4.
    Int J Cardiol. 2023;377:22-25.
    >> Share

  25. LAKE P, Halbach M, Kardasch M, Mauri V, et al
    Comparison of vessel fractional flow reserve with invasive resting full-cycle ratio in patients with intermediate coronary lesions.
    Int J Cardiol. 2023;377:1-8.
    >> Share

  26. REN L, Han Y, Long M, Yan L, et al
    Association with carotid plaque parameters detected on contrast-enhanced ultrasound and coronary artery plaque progression in non-culprit lesions: A retrospective study.
    Int J Cardiol. 2023;377:115-122.
    >> Share

  27. VAN DE HOEF TP, Stegehuis VE, Madera-Cambero MI, van Royen N, et al
    Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-study.
    Int J Cardiol. 2023;377:9-16.
    >> Share

  28. ISHII H
    Cardio-renal interaction in coronary artery disease.
    Int J Cardiol. 2023;377:17-18.
    >> Share

  29. ISHII M, Nakamura T, Tsujita K
    Impact of veno-arterial extracorporeal membrane oxygenation on mortality in cardiogenic shock after acute myocardial infarction: Real-world evidence.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00521.
    >> Share

  30. NAGATA T, Minami Y, Katsura A, Asakura K, et al
    Optical coherence tomography factors for adverse events in patients with severe coronary calcification.
    Int J Cardiol. 2023;376:28-34.
    >> Share

  31. OSAWA K
    Can carotid plaque assessment perform the role of a risk predictor for secondary prevention?
    Int J Cardiol. 2023;376:154-155.
    >> Share

  32. ZHANG ZH
    Thrombospondin-1, a potential target in acute coronary syndrome.
    Int J Cardiol. 2023;376:27.
    >> Share

  33. CARBONE RG, Puppo F
    Breast arterial calcification and epicardial adipose tissue volume: Emerging risk factors of cardiovascular diseases.
    Int J Cardiol. 2023;376:134.
    >> Share

  34. CARBONE RG, Puppo F
    The role of adrenomedullin in acute coronary syndrome.
    Int J Cardiol. 2023;376:22-23.
    >> Share

  35. TSIREBOLOS G, Tsoporis JN, Drosatos IA, Izhar S, et al
    Emerging markers of inflammation and oxidative stress as potential predictors of coronary artery disease.
    Int J Cardiol. 2023;376:127-133.
    >> Share

  36. TSAI TY, Onuma Y, Serruys PW
    Do we still need to perform FFR and PCI?
    Int J Cardiol. 2023;376:48.
    >> Share

  37. MARTIJN S, Maarten F, Danielle Z, Toshiki K, et al
    Psychosocial predictors for cardiac rehabilitation participation for patients with coronary artery disease.
    Int J Cardiol. 2023;376:18-21.
    >> Share

  38. JAMMOUL N, Mercier G, Roubille F
    Could colchicine reduce cardiovascular events in coronary artery disease without increasing all-cause mortality: Avoid optical illusions!
    Int J Cardiol. 2023;376:125-126.
    >> Share

    March 2023
  39. DENEGRI A, Magnani G, Kraler S, Bruno F, et al
    History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities.
    Int J Cardiol. 2023 Mar 21:S0167-5273(23)00454.
    >> Share

  40. POZZI M, Payet C, Polazzi S, L'Hospital A, et al
    Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock after acute myocardial infarction: Insights from a French nationwide database.
    Int J Cardiol. 2023 Mar 20:S0167-5273(23)00446.
    >> Share

  41. MA Z, Wang M, Xu X, Zhang Y, et al
    Thrombospondin-1 plasma levels associated with in-hospital major adverse cardiovascular events in patients with acute coronary syndrome.
    Int J Cardiol. 2023;375:98-103.
    >> Share

  42. BELLINO M, Piscione F
    Spontaneous coronary artery dissection: do we need different tailored strategies?
    Int J Cardiol. 2023;375:7-8.
    >> Share

  43. SIMSEK B, Tajti P, Carlino M, Ojeda S, et al
    External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries.
    Int J Cardiol. 2023;375:14-20.
    >> Share

  44. WANG IC, Lin JH, Lee WS, Liu CH, et al
    Baicalein and luteolin inhibit ischemia/reperfusion-induced ferroptosis in rat cardiomyocytes.
    Int J Cardiol. 2023;375:74-86.
    >> Share

  45. LOPEZ-PALOP R, Lozano I, Carrillo P
    COVID-19 pandemic: National outbreak and acute coronary syndrome. Collateral damages?
    Int J Cardiol. 2023;375:144-146.
    >> Share

  46. BENATTI G, Gragnano F, Vignali L, Calabro P, et al
    Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00393.
    >> Share

  47. SABOUR S
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: Misinterpretation.
    Int J Cardiol. 2023 Mar 10:S0167-5273(23)00365.
    >> Share

  48. KOOLAJI S, Tehrani YS, Azadnajafabad S, Moghaddam SS, et al
    A 30-year trend of ischemic heart disease burden in a developing country; a systematic analysis of the global burden of disease study 2019 in Iran.
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00339.
    >> Share

  49. TANAKA S, Okada K, Kitahara H, Luikart H, et al
    Impact of myocardial bridging on coronary artery plaque formation and long-term mortality after heart transplantation.
    Int J Cardiol. 2023 Mar 7:S0167-5273(23)00343.
    >> Share

  50. DAYEM KA, Younis O, Zarif B, Attia S, et al
    Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).
    Int J Cardiol. 2023 Mar 6:S0167-5273(23)00329.
    >> Share

  51. PELLICCIA F, Camici PG
    Updates on MINOCA and INOCA through the 2022 publications in the International Journal of Cardiology.
    Int J Cardiol. 2023;374:8-11.
    >> Share

  52. WAN M, Lu Y, Mao B, Yu S, et al
    Immature neutrophil is associated with coronary plaque vulnerability based on optical coherence tomography analysis.
    Int J Cardiol. 2023;374:89-93.
    >> Share

  53. SCHINDLER TH, Bhandiwad AR, Jain S
    Role of cardiac magnetic resonance imaging in the prediction of left ventricular remodeling after infarction: Emerging new concepts?
    Int J Cardiol. 2023;374:127-128.
    >> Share

  54. CILIBERTI G, Verdoia M, Musella F, Ceriello L, et al
    MINOCA in Men and Women: Different Conditions and a Single Destiny?
    Int J Cardiol. 2023;374:6-7.
    >> Share

  55. ROSSELLO X, Blaya-Pena L, Siquier-Padilla J
    The COMBO stent: Real-world patients vs. objective performance criteria.
    Int J Cardiol. 2023;374:33-34.
    >> Share

  56. MAHMOUD HT, Berton G, Cordiano R, Palmieri R, et al
    Microalbuminuria during acute coronary syndrome: Association with 22-year mortality and causes of death. The ABC-8* study on heart disease. (*ABC is an acronym for Adria, Bassano, Conegliano, and Padova Hospitals).
    Int J Cardiol. 2023;374:100-107.
    >> Share

  57. XU J, Fan Y, Zhou R, Shao J, et al
    The interaction of persistent antiphospholipid antibodies positivity and cigarette smoking is associated with an increased risk of cardiovascular events: Cross-sectional and longitudinal analysis.
    Int J Cardiol. 2023;374:108-114.
    >> Share

  58. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
    Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease.
    Int J Cardiol. 2023;374:27-32.
    >> Share

    February 2023
  59. D'ASCENZO F, Bruno F, Iannaccone M, Testa G, et al
    Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00256.
    >> Share

  60. DHINDSA DS, Desai SR, Jin Q, Sandesara PB, et al
    Circulating progenitor cells and outcomes in patients with coronary artery disease.
    Int J Cardiol. 2023;373:7-16.
    >> Share

  61. WEINTRAUB WS, Mancini GBJ, Boden WE
    Percutaneous coronary intervention from COURAGE to ISCHEMIA and beyond.
    Int J Cardiol. 2023;373:39-43.
    >> Share

  62. NISHINO M, Egami Y, Kawanami S, Sugae H, et al
    Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction.
    Int J Cardiol. 2023 Feb 14:S0167-5273(23)00237.
    >> Share

  63. WAKABAYASHI K, Higuchi S, Miyachi H, Minatsuki S, et al
    Clinical features and predictors of non-cardiac death in patients hospitalised for acute myocardial infarction: Insights from the Tokyo CCU network multicentre registry.
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00238.
    >> Share

  64. CAMPBELL-QUINTERO S, Echeverria LE, Gomez-Mesa JE, Rivera-Toquica A, et al
    Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Int J Cardiol. 2023 Feb 13:S0167-5273(23)00236.
    >> Share

  65. LIM J, Davies A, Brienesse S, Mabotuwana NS, et al
    Inflammatory cell response following ST-elevation myocardial infarction treated with primary percutaneous coronary intervention and its impact on cardiovascular outcomes: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Feb 7:S0167-5273(23)00123.
    >> Share

  66. CAMERON JD
    Non-hyperemic pressure-derived indices for guiding coronary intervention: Assessing comparative use and application.
    Int J Cardiol. 2023;372:46-47.
    >> Share

  67. WILLIAMS MGL, Dastidar A, Liang K, Johnson TW, et al
    Sex differences in patients with acute coronary syndromes and non-obstructive coronary arteries: Presentation and outcome.
    Int J Cardiol. 2023;372:15-22.
    >> Share

    January 2023
  68. YOSHII T, Matsuzawa Y, Kato S, Sato R, et al
    Endothelial dysfunction predicts bleeding and cardiovascular death in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 31:S0167-5273(23)00121.
    >> Share

  69. PINGITORE A
    Editorial on the manuscript "Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction".
    Int J Cardiol. 2023 Jan 19:S0167-5273(23)00059.
    >> Share

  70. XING Y, Qiu Y, Yang L, Yuan Z, et al
    Cost-effectiveness analysis of screening for peripheral artery disease in patients with coronary artery disease in China: A Markov model.
    Int J Cardiol. 2023;371:420-426.
    >> Share

  71. WONG MYZ, Yap JJL, Chih HJ, Yan BPY, et al
    Regional differences in percutaneous coronary intervention outcomes in STEMI patients with diabetes: The Asia-Pacific evaluation of cardiovascular therapies (ASPECT) collaboration.
    Int J Cardiol. 2023;371:84-91.
    >> Share

  72. NARANG N, Nakamura M, Imamura T
    Disparities in mechanical circulatory support utilization post cardiac arrest: An uncomfortable reality.
    Int J Cardiol. 2023;371:126-127.
    >> Share

  73. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Reply to: Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:80-81.
    >> Share

  74. PICA S, Di Odoardo L, Testa L, Bollati M, et al
    Collateral presence and extent do not predict myocardial viability and ischemia in chronic total occlusions: A stress-CMR study.
    Int J Cardiol. 2023;371:10-15.
    >> Share

  75. KONG G, Chin YH, Chong B, Goh RSJ, et al
    Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients.
    Int J Cardiol. 2023;371:432-440.
    >> Share

  76. FEENSTRA RGT, Seitz A, Boerhout CKM, de Winter RJ, et al
    Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index.
    Int J Cardiol. 2023;371:16-20.
    >> Share

  77. HAO T, Jiang Y, Wu C, Li C, et al
    Clinical outcome and risk factors for acute fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation: An analysis of nationwide CSECLS database in China.
    Int J Cardiol. 2023;371:229-235.
    >> Share

  78. WANG L, Maehara A, Zhang X, Lv R, et al
    Quantification of patient-specific coronary material properties and their correlations with plaque morphological characteristics: An in vivo IVUS study.
    Int J Cardiol. 2023;371:21-27.
    >> Share

  79. GULATI M, Khan N, George M, Berry C, et al
    Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international.
    Int J Cardiol. 2023;371:28-39.
    >> Share

  80. DU L, Wang P, Chen H, Zhang Y, et al
    Among patients with MINOCA women versus men have the increased risks of MACE and stroke?
    Int J Cardiol. 2023;371:82.
    >> Share

  81. DZIEWIERZ A
    The time is always right to do what is right: TAVI and timing of PCI.
    Int J Cardiol. 2023;371:128-129.
    >> Share

  82. AHMED AI, Al Rifai M, Alahdab F, Saad JM, et al
    Incremental prognostic value of digital positron emission tomography derived myocardial flow reserve: A prospective cohort study.
    Int J Cardiol. 2023;371:465-471.
    >> Share

  83. GRAGNANO F, Pelliccia F, Cesaro A, Calabro P, et al
    Geographic variations in percutaneous versus surgical coronary revascularization: A global perspective from the SYNTAXES trial.
    Int J Cardiol. 2023;371:132-134.
    >> Share

  84. SCALONE G, Di Vito L, Mariani L, Silenzi S, et al
    Which therapy for MINOCA patients? "Dazed and confused for so long, it is not true".
    Int J Cardiol. 2023;371:78-79.
    >> Share

  85. GILANI A, Maknojia A, Mufty M, Patel S, et al
    Mechanical circulatory device utilization in cardiac arrest: Racial and gender disparities and impact on mortality.
    Int J Cardiol. 2023;371:460-464.
    >> Share

  86. AW A, de Jong MC, Varghese S, Lee J, et al
    A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy.
    Int J Cardiol. 2023;371:287-292.
    >> Share

  87. FUJII T, Endo S, Tsuchiya R, Nagamatsu H, et al
    Estimation of adverse events associated with P2Y12 receptor inhibitors stratified by academic research consortium for high bleeding risk criteria in acute coronary syndrome.
    Int J Cardiol. 2023 Jan 14:S0167-5273(23)00061.
    >> Share

  88. LIANG J, Zhang Z
    Predictors of in-hospital heart failure in patients with acute anterior wall ST-segment elevation myocardial infarction.
    Int J Cardiol. 2023 Jan 10:S0167-5273(23)00043.
    >> Share

  89. LIARAKOS AL, Tran P, Keegan M, Robbins T, et al
    Real-world evaluation of glucose-lowering therapies and the use of weight-adjusted variable rate intravenous insulin infusion in the management of hyperglycaemia in patients with acute coronary syndrome (REGULATE-ACS).
    Int J Cardiol. 2023;370:26-34.
    >> Share

  90. BULLUCK H, Mozid AM
    Optimising patient selection for CTO PCI - The PICA approach.
    Int J Cardiol. 2023;370:445-446.
    >> Share

  91. PROENCA T, Pinto RA, Carvalho MM, Rocha A, et al
    Sex disparities and dyslipidemic control in a coronary rehabilitation program.
    Int J Cardiol. 2023;370:72-74.
    >> Share

  92. LAENENS D, van der Bijl P, Stassen J, Rossi AC, et al
    Introduction to hemodynamic forces by echocardiography.
    Int J Cardiol. 2023;370:442-444.
    >> Share

  93. SALAMANCA J, Garcia-Guimaraes M, Sabate M, Sanz-Ruiz R, et al
    Multivessel spontaneous coronary artery dissection: Clinical features, angiographic findings, management, and outcomes.
    Int J Cardiol. 2023;370:65-71.
    >> Share

  94. KAMBIC T, Sarabon N, Hadzic V, Lainscak M, et al
    Physical activity and sedentary behaviour following combined aerobic and resistance training in coronary artery disease patients: A randomised controlled trial.
    Int J Cardiol. 2023;370:75-79.
    >> Share

  95. LECHNER I, Reindl M, Reinstadler SJ
    Acute coronary syndrome without standard modifiable cardiovascular risk factors (SMuRF): More questions than answers.
    Int J Cardiol. 2023;370:409-410.
    >> Share

  96. RUSSO G, Pedicino D, Chiastra C, Vinci R, et al
    Coronary artery plaque rupture and erosion: Role of wall shear stress profiling and biological patterns in acute coronary syndromes.
    Int J Cardiol. 2023;370:356-365.
    >> Share

  97. D'ANCONA G, Massussi M, Savardi M, Signoroni A, et al
    Deep learning to detect significant coronary artery disease from plain chest radiographs AI4CAD.
    Int J Cardiol. 2023;370:435-441.
    >> Share

  98. SIMSEK B, Brilakis ES
    Reply to "Letter to the editor in response to the paper by Simsek et al. 2022".
    Int J Cardiol. 2023;370:177.
    >> Share

  99. ABOUL-HASSAN SS, Stankowski T, Marczak J, Perek B, et al
    Long-term outcomes of patients receiving right internal thoracic artery or radial artery as a second arterial conduit. A propensity score matching study.
    Int J Cardiol. 2023;370:136-142.
    >> Share

  100. ARCHILLETTI F, Ricci F, Pelliccia F, Dangas G, et al
    Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
    Int J Cardiol. 2023;370:122-128.
    >> Share

  101. GRIGORIAN-SHAMAGIAN L, Oteo JF, Gutierrez-Barrios A, Abdul-Jawad Altisent O, et al
    Endothelial dysfunction in patients with angina and non-obstructed coronary arteries is associated with an increased risk of mayor cardiovascular events. Results of the Spanish ENDOCOR registry.
    Int J Cardiol. 2023;370:18-25.
    >> Share

  102. QIU M, Luo F, Du L
    SMuRF-less ACS patients have higher risk of mortality?
    Int J Cardiol. 2023;370:83.
    >> Share

  103. SHOJI S, Kohsaka S, Kumamaru H, Nishimura S, et al
    Risk prediction models in patients undergoing percutaneous coronary intervention: A collaborative analysis from a Japanese administrative dataset and nationwide academic procedure registry.
    Int J Cardiol. 2023;370:90-97.
    >> Share

  104. NARDIN M, Pivato CA, Cao D, Sartori S, et al
    The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
    Int J Cardiol. 2023;370:149-155.
    >> Share

  105. ABTAN J, Bhatt DL, Elbez Y, Ducrocq G, et al
    External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued
    Int J Cardiol. 2023;370:51-57.
    >> Share

  106. DI SERAFINO L, Barbato E, Serino F, Svanerud J, et al
    Myocardial mass affects diagnostic performance of non-hyperemic pressure-derived indexes in the assessment of coronary stenosis.
    Int J Cardiol. 2023;370:84-89.
    >> Share

  107. GALLI M, Benenati S, Zito A, Capodanno D, et al
    Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: A network meta-analysis.
    Int J Cardiol. 2023;370:58-64.
    >> Share

  108. ARGIRO A, Zampieri M, Dei LL, Ferrantini C, et al
    Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center.
    Int J Cardiol. 2023;370:271-278.
    >> Share

    December 2022
  109. GALIMZHANOV A, Sabitov Y, Guclu E, Tenekecioglu E, et al
    Phenotyping for percutaneous coronary intervention and long-term recurrent weighted outcomes.
    Int J Cardiol. 2022 Dec 24:S0167-5273(22)01919.
    >> Share

  110. SU W, Song S, Dong H, Wu H, et al
    Identifying and comparing low-value care recommendations for coronary heart disease prevention, diagnosis, and treatment in the US and China.
    Int J Cardiol. 2022 Dec 22:S0167-5273(22)01915.
    >> Share

  111. XIN A, Li K, Yan LL, Chandramouli C, et al
    Machine learning-based prediction of infarct size in patients with ST-segment elevation myocardial infarction: A multi-center study.
    Int J Cardiol. 2022 Dec 21:S0167-5273(22)01918.
    >> Share

  112. ZUIN M, Rigatelli G, Battisti V, Costola G, et al
    Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Dec 16:S0167-5273(22)01914.
    >> Share

  113. MORONI F, Azzalini L, Caixeta A, Oliveira TP, et al
    TIMI flow and myocardial blushing after rescue PCI and cardiac magnetic resonance: Results from the Myocardial Salvage After Rescue Angioplasty: Evaluation by Magnetic Resonance (SAVE-ME) study.
    Int J Cardiol. 2022;369:77-79.
    >> Share

  114. OPSTAL TSJ, Nidorf SM, Fiolet ATL, Eikelboom JW, et al
    Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial.
    Int J Cardiol. 2022 Dec 15:S0167-5273(22)01900.
    >> Share

  115. WANG C, Zhang M, Yan J, Wang R, et al
    Chemokine-like receptor 1 deficiency impedes macrophage phenotypic transformation and cardiac repair after myocardial infarction.
    Int J Cardiol. 2022 Dec 10:S0167-5273(22)01889.
    >> Share

  116. MORTBERG J, Salzinger B, Lundwall K, Edfors R, et al
    Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.
    Int J Cardiol. 2022 Dec 4:S0167-5273(22)01876.
    >> Share

  117. PENG YW, Major T, Deatrick KB, Mohammed A, et al
    Nicorandil attenuates ventricular dysfunction and organ injury after cardiopulmonary bypass.
    Int J Cardiol. 2022;368:62-68.
    >> Share

  118. KAGEYAMA S, Serruys PW, Garg S, Ninomiya K, et al
    Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial.
    Int J Cardiol. 2022;368:28-38.
    >> Share

    November 2022
  119. DU Y, Yuan N, Yan J, Han G, et al
    Identification of echocardiographic subgroups in patients with coronary heart disease combined with heart failure based on latent variable stratification.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01725.
    >> Share

  120. DASA O, Pepine CJ, Pearson TA
    An international perspective on low-dose aspirin for the primary prevention of myocardial infarction.
    Int J Cardiol. 2022 Nov 25:S0167-5273(22)01723.
    >> Share

  121. GROENLAND FTW, Huang J, Scoccia A, Neleman T, et al
    Vessel fractional flow reserve-based non-culprit lesion reclassification in patients with ST-segment elevation myocardial infarction: Impact on treatment strategy and clinical outcome (FAST STEMI I study).
    Int J Cardiol. 2022 Nov 24:S0167-5273(22)01730.
    >> Share

  122. GARCIA-GUIMARAES M, Sanz-Ruiz R, Sabate M, Velazquez-Martin M, et al
    Spontaneous coronary artery dissection and ST-segment elevation myocardial infarction: Does clinical presentation matter?
    Int J Cardiol. 2022 Nov 23:S0167-5273(22)01720.
    >> Share

  123. YOON YH, Park GM, Lee JY, Lee JH, et al
    Relationship between sexual differences and cardiovascular risk factors in the prevalence of asymptomatic coronary disease.
    Int J Cardiol. 2022 Nov 19:S0167-5273(22)01709.
    >> Share

  124. JUNG C, Rezar R, Wischmann P, Masyuk M, et al
    The role of anemia on admission in acute coronary syndrome - An umbrella review of systematic reviews and meta-analyses.
    Int J Cardiol. 2022;367:1-10.
    >> Share

  125. GONZALEZ-DEL-HOYO M, Rodriguez-Leor O, Cid-Alvarez AB, de Prado AP, et al
    Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort.
    Int J Cardiol. 2022;367:90-98.
    >> Share

  126. HOLZKNECHT M, Lechner I, Reinstadler SJ
    The circadian clock in STEMI: A further contributor to the development of MVO?
    Int J Cardiol. 2022;367:115-116.
    >> Share

  127. WANG J, Li Y, Zhang S
    N(6)-methyladenosine modification: A vital role of programmed cell death in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;367:11-19.
    >> Share

  128. SIMSEK B, Jaffer FA, Kostantinis S, Karacsonyi J, et al
    Preprocedural coronary computed tomography angiography in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Int J Cardiol. 2022;367:20-25.
    >> Share

  129. ZUERCHER MD, Harvey DJ, Au LE, Shadyab AH, et al
    Genetic admixture and cardiovascular disease risk in postmenopausal Hispanic women.
    Int J Cardiol. 2022;367:99-104.
    >> Share

  130. BOERHOUT CKM, de Waard GA, Lee JM, Mejia-Renteria H, et al
    Combined use of hyperemic and non-hyperemic pressure ratios for revascularization decision-making: From the ILIAS registry.
    Int J Cardiol. 2022 Nov 11:S0167-5273(22)01702.
    >> Share

  131. DE LUCA L, Rosato S, D'Errigo P, Giordani B, et al
    Covid-19 diagnosis and mortality in patients with non-ST-elevation myocardial infarction admitted in Italy during the national outbreak.
    Int J Cardiol. 2022 Nov 7. pii: S0167-5273(22)01695.
    >> Share

  132. PICA S, Crimi G, Castelvecchio S, Pazzanese V, et al
    Cardiac magnetic resonance predictors of left ventricular remodelling following acute ST elevation myocardial infarction: The VavirimS study.
    Int J Cardiol. 2022 Nov 6. pii: S0167-5273(22)01693.
    >> Share

  133. TORGUSON R, Mintz GS, Case BC, Di Mario C, et al
    Correlation between lipidic content and arterial-wall plaque burden: A Lipid Rich Plaque study sub-analysis.
    Int J Cardiol. 2022;366:32-34.
    >> Share

    October 2022
  134. PARK HW, Ozcan I, Toya T, Ahmad A, et al
    Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Int J Cardiol. 2022 Oct 29. pii: S0167-5273(22)01670.
    >> Share

  135. TRAUB J, Schurmann P, Schmitt D, Gassenmaier T, et al
    Features of metabolic syndrome and inflammation independently affect left ventricular function early after first myocardial infarction.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01653.
    >> Share

  136. DE FILIPPO O, D'Ascenzo F, Wojciech W, Leonardi S, et al
    IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.
    Int J Cardiol. 2022 Oct 25. pii: S0167-5273(22)01658.
    >> Share

  137. VANDENBRIELE C, Van Edom C, Tavazzi G
    Anticoagulant management for transition from failed thrombolysis to extra-corporeal membrane oxygenation in patients with high-risk pulmonary embolism: A thoughtful approach.
    Int J Cardiol. 2022 Oct 22. pii: S0167-5273(22)01649.
    >> Share

  138. RUSSO M, Jang IK
    Cholesterol crystals in atherosclerotic plaques: A future target to reduce the risk of plaque rupture?
    Int J Cardiol. 2022;365:30-31.
    >> Share

  139. MORRONE D, Gentile F, Aimo A, Cameli M, et al
    Perspectives in noninvasive imaging for chronic coronary syndromes.
    Int J Cardiol. 2022;365:19-29.
    >> Share

  140. HONTON B, Lipiecki J, Monsegu J, Leroy F, et al
    Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative.
    Int J Cardiol. 2022;365:106-111.
    >> Share

  141. BEREZIN AE
    Signature of standard modifiable CV factors as unrecognizable risk factor of in-hospital mortality in patients with acute myocardial infarction.
    Int J Cardiol. 2022 Oct 7. pii: S0167-5273(22)01479.
    >> Share

  142. FITZGERALD BT, Smith E, Scalia GM
    What are the prognostic implications and factors relating to exercise induced electrocardiographic ST segment changes in the setting of a non-ischemic stress echocardiogram?
    Int J Cardiol. 2022;364:157-161.
    >> Share

  143. QIN Z, Cao M, Xi X, Zhang Y, et al
    Cholesterol crystals in non-culprit plaques of STEMI patients: A 3-vessel OCT study.
    Int J Cardiol. 2022;364:162-168.
    >> Share

  144. COSENTINO N, Lucci C, Marenzi G
    Inflammation and left ventricular thrombosis after STEMI: Risk marker or risk factor?
    Int J Cardiol. 2022;364:16-17.
    >> Share

  145. YASUE H
    Coronary artery spasm: not rare but not fully understood yet.
    Int J Cardiol. 2022;364:18-19.
    >> Share

  146. WANG J, Li C, Ding D, Zhang M, et al
    Functional comparison of different jailed balloon techniques in treating non-left main coronary bifurcation lesions.
    Int J Cardiol. 2022;364:20-26.
    >> Share

    September 2022
  147. LI L, Tu B, Liu S, Zhang Z, et al
    Sex differences in ventricular arrhythmias epidemiology, risk factors, and mortality in congestive heart failure.
    Int J Cardiol. 2022 Sep 28. pii: S0167-5273(22)01415.
    >> Share

  148. DOMENICO T, Rita A, Giacomo S, Diego A, et al
    Salivary biomarkers for diagnosis of acute myocardial infarction: A systematic review.
    Int J Cardiol. 2022 Sep 24. pii: S0167-5273(22)01393.
    >> Share

  149. SAJID DS, Bokhari SFH
    Comment on "Single troponin measurement to rule-out acute myocardial infarction in early presenters".
    Int J Cardiol. 2022 Sep 21. pii: S0167-5273(22)01389.
    >> Share

  150. SOKHAL BS, Matetic A, Paul TK, Velagapudi P, et al
    Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors.
    Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01387.
    >> Share

  151. DENNIS M, Howpage S, McGill M, Dutta S, et al
    Myocardial fibrosis in Type 2 Diabetes is associated with functional and metabolomic parameters.
    Int J Cardiol. 2022;363:179-184.
    >> Share

  152. DI FUSCO SA, Cianfrocca C, Bisceglia I, Spinelli A, et al
    Potential pathophysiologic mechanisms underlying the inherent risk of cancer in patients with atherosclerotic cardiovascular disease.
    Int J Cardiol. 2022;363:190-195.
    >> Share

  153. ATTAR R, Valentin JB, Andell P, Nielsen RE, et al
    Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.
    Int J Cardiol. 2022;363:1-5.
    >> Share

  154. YAMAMOTO T, Ishii T, Ishida A
    Impact of post physiological assessment after treatment for de novo coronary lesions using drug-coated balloons.
    Int J Cardiol. 2022;363:11-19.
    >> Share

  155. LIN HC, Chou SH, Fan PC, Zhu Z, et al
    The association between Day-1 urine cadmium excretion and 30-day mortality in patients with acute myocardial infarction: A multi-institutional cohort study.
    Int J Cardiol. 2022 Sep 11. pii: S0167-5273(22)01321.
    >> Share

  156. MICHELSEN HO, Henriksson P, Wallert J, Back M, et al
    Organizational and patient-level predictors for attaining key risk factor targets in cardiac rehabilitation after myocardial infarction: The perfect-CR study.
    Int J Cardiol. 2022 Sep 8. pii: S0167-5273(22)01322.
    >> Share

  157. SHARMA A, Gupta I, Venkatesh U, Singh AK, et al
    E-cigarettes and myocardial infarction: A systematic review and Meta-analysis.
    Int J Cardiol. 2022 Sep 7. pii: S0167-5273(22)01315.
    >> Share

  158. RAM P, Shah S, Patel B, Osman M, et al
    Outcomes among heart transplant recipients following acute coronary syndrome: A Nationwide population based study.
    Int J Cardiol. 2022 Sep 5. pii: S0167-5273(22)01267.
    >> Share

  159. WIENEMANN H, Ameskamp C, Mejia-Renteria H, Mauri V, et al
    Diagnostic performance of quantitative flow ratio versus fractional flow reserve and resting full-cycle ratio in intermediate coronary lesions.
    Int J Cardiol. 2022;362:59-67.
    >> Share

  160. MATSUBAYASHI K, Soeda T
    Significance of superficial macrophage cluster in coronary atherosclerotic plaque.
    Int J Cardiol. 2022;362:24-25.
    >> Share

  161. STATHOGIANNIS K, Fearon WF
    Untangling diffuse CAD: Light at the end of the tunnel?
    Int J Cardiol. 2022;362:20-21.
    >> Share

  162. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Prevalence and outcomes of balloon undilatable chronic total occlusions: Insights from the PROGRESS-CTO.
    Int J Cardiol. 2022;362:42-46.
    >> Share

    August 2022
  163. DEMIRKIRAN A, van der Geest RJ, Hopman LHGA, Robbers LFHJ, et al
    Association of left ventricular flow energetics with remodeling after myocardial infarction: New hemodynamic insights for left ventricular remodeling.
    Int J Cardiol. 2022 Aug 22. pii: S0167-5273(22)01250.
    >> Share

  164. GHAJAR A, Ordonez CP, Philips B, Pinzon PQ, et al
    Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes.
    Int J Cardiol. 2022 Aug 21. pii: S0167-5273(22)01253.
    >> Share

  165. STAHLI BE, Witassek FF, Roffi M, Eberli FR, et al
    Trends in treatment and outcomes of patients with diabetes and acute myocardial infarction: Insights from the nationwide AMIS plus registry.
    Int J Cardiol. 2022 Aug 19. pii: S0167-5273(22)01200.
    >> Share

  166. DE FILIPPO O, Russo C, Manai R, Borzillo I, et al
    Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
    Int J Cardiol. 2022 Aug 17. pii: S0167-5273(22)01201.
    >> Share

  167. MALHOTRA P, Han D
    Imaging tests for coronary artery disease risk assessment: Anatomy, physiology, or both?
    Int J Cardiol. 2022;361:124-125.
    >> Share

  168. GAUTHIER V, Montaye M, Ferrieres J, Kai SHY, et al
    Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries.
    Int J Cardiol. 2022;361:103-108.
    >> Share

  169. GALLINORO E, Almendarez M, Alvarez-Velasco R, Barbato E, et al
    Bioresorbable stents: Is the game over?
    Int J Cardiol. 2022;361:20-28.
    >> Share

  170. MYHRE PL, Rosjo H, Sarvari SI, Ukkonen H, et al
    Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
    Int J Cardiol. 2022;361:14-17.
    >> Share

  171. TANG LH, Harrison A, Skou ST, Taylor RS, et al
    Are patient characteristics and modes of delivery associated with completion of cardiac rehabilitation? A national registry analysis.
    Int J Cardiol. 2022;361:7-13.
    >> Share

  172. MARBACH JA, Faugno AJ, Pacifici S, Chweich H, et al
    Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: A systematic review and Meta-analysis.
    Int J Cardiol. 2022;361:77-84.
    >> Share

  173. LI Q, Xie E, Tu Y, Wu Y, et al
    Association between kaolin-induced maximum amplitude and slow-flow/no-reflow in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
    Int J Cardiol. 2022 Aug 12. pii: S0167-5273(22)01193.
    >> Share

  174. CHEN Y, Wu J, Tang Y, Li Z, et al
    Multimorbidity and combined interventions for patients with coronary heart disease in Chinese population: Latent class analysis of a multi-center study.
    Int J Cardiol. 2022 Aug 10. pii: S0167-5273(22)01189.
    >> Share

  175. TSCHOPE C, Nelki V, Trippel TD, Klingel K, et al
    Safety and usefulness of left ventricular endomyocardial biopsy in new- onset acute heart failure requiring mechanical support by an Impella(R) device.
    Int J Cardiol. 2022 Aug 6. pii: S0167-5273(22)01176.
    >> Share

  176. GRAZIANI F, Lillo R, Biagini E, Limongelli G, et al
    Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease.
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01116.
    >> Share

  177. LIM HS
    How does protocolization improve outcomes in cardiogenic shock due to end-stage heart failure?
    Int J Cardiol. 2022 Aug 2. pii: S0167-5273(22)01115.
    >> Share

  178. HWANG R, Peters R, Harmer E, Boyde M, et al
    Insight into a real-world experience with completion of cardiac rehabilitation.
    Int J Cardiol. 2022;360:5-6.
    >> Share

  179. GOEL V, Spear E, Cameron W, Thakur U, et al
    Breast arterial calcification and epicardial adipose tissue volume, but not density are independently associated with cardiovascular risk.
    Int J Cardiol. 2022;360:78-82.
    >> Share

  180. NAKAJIMA K, Yoshida S
    Small coronary artery matters: Non-dominant right coronary artery and perfusion imaging.
    Int J Cardiol. 2022;360:101-103.
    >> Share

  181. SEITZ A, Martinez Pereyra V, Hubert A, Klingel K, et al
    Epicardial and microvascular coronary artery spasm in biopsy-proven viral myocarditis.
    Int J Cardiol. 2022;360:1-4.
    >> Share

  182. CHAUDHARY R, Bashline M, Novelli EM, Bliden KP, et al
    Sex-related differences in clinical outcomes among patients with myocardial infarction with nonobstructive coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Aug 1. pii: S0167-5273(22)01120.
    >> Share

    July 2022
  183. DE LUCA G, Verdoia M, Morici N, Ferri LA, et al
    Impact of hemoglobin levels at admission on outcomes among elderly patients with acute coronary syndrome treated with low-dose Prasugrel or clopidogrel: A sub-study of the ELDERLY ACS 2 trial.
    Int J Cardiol. 2022 Jul 27. pii: S0167-5273(22)01104.
    >> Share

  184. LUNARDI M, Venturi G, Del Sole PA, Ruzzarin A, et al
    Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Int J Cardiol. 2022 Jul 21. pii: S0167-5273(22)01100.
    >> Share

  185. SEITZ A, Martinez Pereyra V, Sechtem U, Ong P, et al
    Update on coronary artery spasm 2022 - A narrative review.
    Int J Cardiol. 2022;359:1-6.
    >> Share

  186. DIXON LK, Akberali U, Di Tommaso E, George SJ, et al
    Hybrid coronary revascularization versus coronary artery bypass grafting for multivessel coronary artery disease: A systematic review and meta-analysis.
    Int J Cardiol. 2022;359:20-27.
    >> Share

  187. NELEMAN T, Scoccia A, Masdjedi K, Tomaniak M, et al
    The prognostic value of angiography-based vessel fractional flow reserve after percutaneous coronary intervention: The FAST Outcome study.
    Int J Cardiol. 2022;359:14-19.
    >> Share

  188. ZHANG L, Fu Z, Huang Y, Luo W, et al
    LOXL1-AS1 alleviates inflammatory response in the epicardial adipose tissue with coronary artery disease by sponging miR-3614.
    Int J Cardiol. 2022;359:113.
    >> Share

  189. PRESCOTT E, Angeras O, Erlinge D, Grove EL, et al
    Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study.
    Int J Cardiol. 2022 Jul 13. pii: S0167-5273(22)01084.
    >> Share

  190. BONFIG NL, Soukup CR, Shah AA, Davidson S, et al
    Circadian dependence of microvascular obstruction during ST-segment elevation myocardial infarction.
    Int J Cardiol. 2022 Jul 8. pii: S0167-5273(22)01036.
    >> Share

  191. MPLANI V, Apostolopoulos D, Koufou E, Spyridonidis T, et al
    Inferior myocardial wall ischemia on SPECT-MPI in patients with non dominant right coronary artery and non significant coronary artery disease.
    Int J Cardiol. 2022;358:8-10.
    >> Share

  192. XU JJ, Cui J, Lin Q, Chen XY, et al
    Response to "Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury".
    Int J Cardiol. 2022;358:11.
    >> Share

  193. JAVAID A, Ahmed AI, Han Y, Al Rifai M, et al
    Incremental prognostic value of spect over CCTA.
    Int J Cardiol. 2022;358:120-127.
    >> Share

  194. YU K, Yang C, Liu J, Mo D, et al
    GATA2 might be used to predict the susceptibility of people to coronary artery disease.
    Int J Cardiol. 2022;358:94.
    >> Share

    June 2022
  195. ORBAN M, Kuehl A, Dischl D, Muller C, et al
    Fibrotic plaques in heart transplanted patients and their association with insulin resistance syndrome and Lp(a).
    Int J Cardiol. 2022 Jun 27. pii: S0167-5273(22)01015.
    >> Share

  196. BAKER HE, Tune JD, Mather KJ, Blaettner BS, et al
    Acute SGLT-2i treatment improves cardiac efficiency during myocardial ischemia independent of Na+/H+ exchanger-1.
    Int J Cardiol. 2022 Jun 23. pii: S0167-5273(22)01006.
    >> Share

  197. YAN H, Zhao N, Geng W, Hou Z, et al
    Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions.
    Int J Cardiol. 2022;357:8-13.
    >> Share

  198. KIM HO, Jiang B, Poon EKW, Thondapu V, et al
    High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Int J Cardiol. 2022;357:1-7.
    >> Share

  199. HIGASHIOKA D, Shiono Y, Emori H, Khalifa AKM, et al
    Prevalence of myocardial perfusion scintigraphy derived ischemia in coronary lesions with discordant fractional flow reserve and non-hyperemic pressure ratios.
    Int J Cardiol. 2022;357:20-25.
    >> Share

  200. NGUYEN HL, Bui QT, Tran HV, Hoang MV, et al
    Characteristics, in-hospital management, and complications of acute myocardial infarction in northern and Central Vietnam.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00943.
    >> Share

  201. SUN M, Dube MP, Hennessy T, Schultz CJ, et al
    Low-dose colchicine and high-sensitivity C-reactive protein after myocardial infarction: A combined analysis using individual patient data from the COLCOT and LoDoCo-MI studies.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00926.
    >> Share

  202. SOLLI CN, Chamat-Hedemand S, Elming H, Ngo A, et al
    Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms.
    Int J Cardiol. 2022 Jun 15. pii: S0167-5273(22)00928.
    >> Share

  203. CHOI YJ, Park MJ, Ko Y, Soh MS, et al
    Artificial intelligence versus physicians on interpretation of printed ECG images: Diagnostic performance of ST-elevation myocardial infarction on electrocardiography.
    Int J Cardiol. 2022 Jun 9. pii: S0167-5273(22)00869.
    >> Share

  204. MIR T, Uddin M, Changal K, Qureshi W, et al
    Mortality outcomes and 30-day readmissions associated with coronary artery aneurysms; a National Database Study.
    Int J Cardiol. 2022;356:6-11.
    >> Share

  205. ROONGSANGMANOON W, Wongsoasup A, Angkananard T, Rattanajaruskul N, et al
    Comparison of efficacy and safety of intracoronary nicardipine and adenosine for fractional flow reserve assessment of coronary stenosis.
    Int J Cardiol. 2022;356:1-5.
    >> Share

  206. KAVSAK PA, Mondoux SE, Ainsworth C, Worster A, et al
    High-sensitivity cardiac troponin and the importance of cutoffs in patients with prior coronary artery bypass grafting with suspected NSTEMI.
    Int J Cardiol. 2022;356:36-37.
    >> Share

  207. AKIMARU K, Iwabuchi M, Ishida A, Uehara H, et al
    Comparative evaluation of standard maintenance-dose clopidogrel versus low-dose prasugrel in patients with stable coronary artery disease after percutaneous coronary intervention.
    Int J Cardiol. 2022;356:30-35.
    >> Share

  208. SIMONI AH, Frydenlund J, Kragholm KH, Boggild H, et al
    Socioeconomic inequity in incidence, outcomes and care for acute coronary syndrome: A systematic review.
    Int J Cardiol. 2022;356:19-29.
    >> Share

    May 2022
  209. KE Y, Wang J, Wang W, Guo S, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: A systematic review and network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2022 May 30. pii: S0167-5273(22)00807.
    >> Share

  210. PIVATO CA, Chandiramani R, Petrovic M, Nicolas J, et al
    Depression and ischemic heart disease.
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00767.
    >> Share

  211. TRAVERSE JH
    When should patients with acute myocardial infarction undergo CABG? A question much in need of a randomized clinical trial?
    Int J Cardiol. 2022 May 25. pii: S0167-5273(22)00768.
    >> Share

  212. BERNARDI M, Spadafora L, Biondi-Zoccai G, Giordano A, et al
    Juvenile myocardial infarction: Sex matters.
    Int J Cardiol. 2022 May 23. pii: S0167-5273(22)00757.
    >> Share

  213. FLORIAN A
    Predicting LV thrombosis after acute myocardial infarction: From Virchow's triad to state-of-the-art cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2022 May 18. pii: S0167-5273(22)00745.
    >> Share

  214. LI Q, Li Z, Li T, Liu C, et al
    Involvement of the crosstalk between Nrf2 and NF-kappaB pathways regulated by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2022;355:44.
    >> Share

  215. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Effects of left ventricular mass on computed tomography derived fractional flow reserve in significant obstructive coronary artery disease.
    Int J Cardiol. 2022;355:59-64.
    >> Share

  216. HOLZKNECHT M, Reinstadler SJ
    CRP: a potential target in reperfused STEMI? Reply to the letter: "Targeting CRP in microvascular obstruction after PCI".
    Int J Cardiol. 2022;355:5.
    >> Share

  217. DIEU X, Chabrun F, Prunier F, Angoulvant D, et al
    Post-infarct cardiac remodeling predictions with machine learning.
    Int J Cardiol. 2022;355:1-4.
    >> Share

  218. SVARTSTEIN AW, Lassen MH, Skaarup KG, Grove GL, et al
    Predictive value of left atrial strain in relation to atrial fibrillation following acute myocardial infarction.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00736.
    >> Share

  219. SHETTY MK, Kunal S, Girish MP, Qamar A, et al
    Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) Registry.
    Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00734.
    >> Share

  220. LECHNER I, Reindl M, Tiller C, Holzknecht M, et al
    Association between inflammation and left ventricular thrombus formation following ST-elevation myocardial infarction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00660.
    >> Share

  221. IANNACCONE M, Franchin L, Hanson ID, Boccuzzi G, et al
    Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00662.
    >> Share

  222. MA F, Hao J, Zhao J, Liu DY, et al
    Circulating FAM19A5 level is associated with the presence and severity of coronary artery disease.
    Int J Cardiol. 2022;354:50-55.
    >> Share

  223. GRAGNANO F, Cesaro A, Pelliccia F, Limongelli G, et al
    Early-onset MINOCA: Prognostic implications and considerations for practice.
    Int J Cardiol. 2022;354:14-16.
    >> Share

  224. HITOMI Y, Masaki N, Ishinoda Y, Ido Y, et al
    Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality.
    Int J Cardiol. 2022;354:43-47.
    >> Share

  225. KOECHLIN L, Boeddinghaus J, Nestelberger T, Lopez-Ayala P, et al
    Lower diagnostic accuracy of hs-cTnI in patients with prior coronary artery bypass grafting.
    Int J Cardiol. 2022;354:1-6.
    >> Share

    April 2022
  226. WANG Z, Li T, Li M, Gu W, et al
    MALAT1 aggravates cardiomyocytes injury in myocardial infarction by sponging miR-135b.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00636.
    >> Share

  227. LI J, Chen R, Zhou J, Wang Y, et al
    The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00634.
    >> Share

  228. BENEDETTO U, Sinha S, Mulla A, Glampson B, et al
    Implications of elevated troponin on time-to-surgery in non-ST elevation myocardial infarction (NIHR Health Informatics Collaborative: TROP-CABG study).
    Int J Cardiol. 2022 Apr 26. pii: S0167-5273(22)00586.
    >> Share

  229. FERRELL MC, Elizabeth Garrett BA, Alicia Tomlin DO, Cole Wayant DO, et al
    Editorial conflicts of interest related to the Management of Stable Ischemic Heart Disease.
    Int J Cardiol. 2022 Apr 22. pii: S0167-5273(22)00569.
    >> Share

  230. ORBAN M, Dietl M, Dischl D, von Samson-Himmelstjerna P, et al
    Assessment of sex- and age-dependency of risk factors for intimal hyperplasia in heart transplant patients using the high resolution of optical coherence tomography.
    Int J Cardiol. 2022 Apr 18. pii: S0167-5273(22)00556.
    >> Share

  231. CAO M, Luo H, Li D, Wang S, et al
    Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases.
    Int J Cardiol. 2022;353:109-117.
    >> Share

  232. SCICALI R
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease.
    Int J Cardiol. 2022;353:118.
    >> Share

  233. ZHAO Z, Shi Q, Guo Q, Peng L, et al
    Remote ischemic preconditioning can extend the tolerance to extended drug-coated balloon inflation time by reducing myocardial damage during percutaneous coronary intervention.
    Int J Cardiol. 2022;353:3-8.
    >> Share

  234. D'ASCENZO F, Elia E, de Filippo O, Manai R, et al
    Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
    Int J Cardiol. 2022;353:9-14.
    >> Share

  235. NANDHAKUMAR V, Pakshirajan B, Chopra A, Anandan H, et al
    Safety and feasibility of intravascular ultrasound guided zero-contrast percutaneous coronary intervention-A prospective study.
    Int J Cardiol. 2022;353:22-28.
    >> Share

  236. MASSUSSI M, Cipriani A, Meneghin S, De la Cruz N, et al
    Prognostic value of left ventricular blood stasis in patients with acute myocardial infarction: A cardiac magnetic resonance study.
    Int J Cardiol. 2022 Apr 6. pii: S0167-5273(22)00492.
    >> Share

  237. BOTTO GL, Mantovani LG, Cortesi PA, De Ponti R, et al
    The value of wearable cardioverter defibrillator in adult patients with recent myocardial infarction: Economic and clinical implications from a health technology assessment perspective.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00483.
    >> Share

  238. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    >> Share

  239. ONG P, Allgauer S
    Factors influencing medical care of STEMI patients during the COVID-19 pandemic worldwide.
    Int J Cardiol. 2022;352:195-196.
    >> Share

  240. LV R, Wang L, Maehara A, Guo X, et al
    Image-based biomechanical modeling for coronary atherosclerotic plaque progression and vulnerability prediction.
    Int J Cardiol. 2022;352:1-8.
    >> Share

  241. VYNCKIER P, Kotseva K, Gevaert S, De Bacquer D, et al
    Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry.
    Int J Cardiol. 2022;352:152-157.
    >> Share

  242. GALLINORO E, Monizzi G, Sonck J, Candreva A, et al
    Physiological and angiographic outcomes of PCI in calcified lesions after rotational atherectomy or intravascular lithotripsy.
    Int J Cardiol. 2022;352:27-32.
    >> Share

  243. ZHANG D, Wu H, Liu D, Li Y, et al
    Targeting CRP in microvascular obstruction after PCI.
    Int J Cardiol. 2022;352:124.
    >> Share

  244. ZHANG R, Xu B, Dou K, Guan C, et al
    Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality.
    Int J Cardiol. 2022;352:33-39.
    >> Share

  245. SCHAFER A
    Clopidogrel or ticagrelor in elderly patients with acute coronary syndromes - Nihil nocere!
    Int J Cardiol. 2022;352:19-20.
    >> Share

  246. VAN BEEK KAJ, van Steenbergen GJ, Vervaat FE, Mulders BCJH, et al
    Single center experience in the treatment of hemodynamically significant diffuse coronary artery disease of the left anterior descending.
    Int J Cardiol. 2022;352:40-44.
    >> Share

  247. MASCI PG, Bogaert J
    Implementing the risk stratification in STEMI by cardiovascular magnetic resonance: An academic exercise or real benefit?
    Int J Cardiol. 2022;352:188-189.
    >> Share

    March 2022
  248. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    >> Share

  249. ZHANG Y
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Mar 18. pii: S0167-5273(22)00389.
    >> Share

  250. GONZALEZ FERRERO T, Alvarez Alvarez B, Cordero A, Martinon Martinez J, et al
    Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry.
    Int J Cardiol. 2022;351:8-14.
    >> Share

  251. DEMIRCI D, Demirci DE, Chi G
    Association between obesity grade and the age of the first acute coronary syndrome: Prospective observational study.
    Int J Cardiol. 2022;351:93-99.
    >> Share

  252. REINSTADLER SJ, Dlaska C, Reindl M, Marks M, et al
    Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00335.
    >> Share

  253. BRUNO F, Moirano G, Budano C, Lalloni S, et al
    Incidence trends and long-term outcomes of myocardial infarction in young adults: Does gender matter?
    Int J Cardiol. 2022 Mar 14. pii: S0167-5273(22)00331.
    >> Share

  254. CIFKOVA R
    Gender differences in secondary prevention of coronary heart disease: Far from closing the gap.
    Int J Cardiol. 2022 Mar 10. pii: S0167-5273(22)00322.
    >> Share

  255. MONTINARI MR, Minelli P, Russo A, Gianicolo E, et al
    Patterns of coronary heart disease mortality in Italy from 1931 to 2015 and a focus on a region with highly industrialized areas.
    Int J Cardiol. 2022 Mar 9. pii: S0167-5273(22)00326.
    >> Share

  256. ZANCHIN C, Ledwoch S, Bar S, Ueki Y, et al
    Acute coronary syndromes in young patients: Phenotypes, causes and clinical outcomes following percutaneous coronary interventions.
    Int J Cardiol. 2022;350:1-8.
    >> Share

  257. PENG J, Xing CY, Zhao K, Deng J, et al
    Associations of pro-protein convertase subtilisin-like kexin type 9, soluble low-density lipoprotein receptor and coronary artery disease: A case-control study.
    Int J Cardiol. 2022;350:9-15.
    >> Share

  258. MATSUI S, Maruhashi T, Kishimoto S, Kajikawa M, et al
    Poor tooth brushing behavior is associated with high risk of cardiovascular events: A prospective observational study.
    Int J Cardiol. 2022;350:111-117.
    >> Share

  259. WU J, Huang Y, Zhang J, Xiang Z, et al
    LncRNA CPhar mediates exercise-induced cardioprotection by promoting eNOS phosphorylation at Ser1177 via DDX17/PI3K/Akt pathway after MI/RI.
    Int J Cardiol. 2022;350:16.
    >> Share

    February 2022
  260. LU Y, Tian Y, Mou T, Zhou Y, et al
    Transient cardioprotective effects of remote ischemic postconditioning on non-reperfused myocardial infarction: longitudinal evaluation study in pigs.
    Int J Cardiol. 2022 Feb 18. pii: S0167-5273(22)00257.
    >> Share

  261. TILLER C, Reindl M, Reinstadler SJ, Klug G, et al
    The classical 12lead ECG: Much more to offer than just a diagnosis in STEMI?
    Int J Cardiol. 2022;349:29-30.
    >> Share

  262. FUJISUE K, Yamamoto E, Sueta D, Takae M, et al
    Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome.
    Int J Cardiol. 2022;349:1-6.
    >> Share

  263. FERRO A
    Antithrombotic therapy after 1 year of dual antiplatelet therapy following acute coronary syndrome: What to do?
    Int J Cardiol. 2022;349:27-28.
    >> Share

  264. SAITO Y, Saito Y, Kato K, Kobayashi Y, et al
    Gender differences in factors associated with vasospastic angina.
    Int J Cardiol. 2022;349:7-11.
    >> Share

  265. MAGNANI G, Bricoli S, Ardissino M, Maglietta G, et al
    Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA).
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00249.
    >> Share

  266. FAGA V, Anguera I, Oloriz T, Nombela-Franco L, et al
    Improved prediction of electrical storm in patients with prior myocardial infarction and implantable cardioverter defibrillator.
    Int J Cardiol. 2022 Feb 14. pii: S0167-5273(22)00251.
    >> Share

  267. MANTOVANI A, Bonapace S, Dugo C, Beatrice G, et al
    Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure.
    Int J Cardiol. 2022 Feb 12. pii: S0167-5273(22)00248.
    >> Share

  268. MARENGO G, De Filippo O, D'Ascenzo F, Iannaccone M, et al
    IVUS guided PCI in patients with acute myocardial infarction - The route toward a "plaque oriented" PCI.
    Int J Cardiol. 2022 Feb 11. pii: S0167-5273(22)00246.
    >> Share

  269. GIRERD N
    The growing importance of heart failure in myocardial infarction.
    Int J Cardiol. 2022 Feb 5. pii: S0167-5273(22)00194.
    >> Share

  270. HOLZKNECHT M, Klug G, Metzler B, Reinstadler SJ, et al
    Mechanical complications after STEMI: Another collateral damage of the COVID-19 pandemic.
    Int J Cardiol. 2022;348:23-25.
    >> Share

  271. ASAKURA K, Minami Y, Kinoshita D, Katamine M, et al
    Impact of triglyceride levels on plaque characteristics in patients with coronary artery disease.
    Int J Cardiol. 2022;348:134-139.
    >> Share

  272. XU X, Fam JM, Low AFH, Tan RS, et al
    Sex differences in assessing stenosis severity between physician visual assessment and quantitative coronary angiography.
    Int J Cardiol. 2022;348:9-14.
    >> Share

  273. ALFONSO F, Rivero F, Cortese B
    Excimer laser prior to drug-coated balloon treatment of in-stent restenosis.
    Int J Cardiol. 2022;348:47-49.
    >> Share

  274. ORSINI E, Marzilli M, Zito GB, Carbone V, et al
    Clinical outcomes of newly diagnosed, stable angina patients managed according to current guidelines. The ARCA (Arca Registry for Chronic Angina) Registry: A prospective, observational, nationwide study.
    Int J Cardiol. 2022 Feb 1. pii: S0167-5273(22)00182.
    >> Share

    January 2022
  275. FU EL, Clase CM, Janse RJ, Lindholm B, et al
    Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice.
    Int J Cardiol. 2022 Jan 21. pii: S0167-5273(22)00131.
    >> Share

  276. GROENLAND FTW, Neleman T, Kakar H, Scoccia A, et al
    Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis.
    Int J Cardiol. 2022 Jan 15. pii: S0167-5273(22)00068.
    >> Share

  277. ADLAM D, Zarebinski M, Uren NG, Ptaszynski P, et al
    A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Int J Cardiol. 2022;347:1-7.
    >> Share

  278. PERFETTI M, Di Nicola M, Zimarino M
    Asimmetric uncertainties and account balance. Editorial to "Instantaneous wave-free ratio compared with fractional flow 2 reserve in PCI: A cost-minimization analysis".
    Int J Cardiol. 2022;347:19-20.
    >> Share

  279. KHAN E, Lambrakis K, Nazir SA, Chuang A, et al
    Implementation of more sensitive cardiac troponin T assay in a state-wide health service.
    Int J Cardiol. 2022;347:66-72.
    >> Share

  280. MA P, Liu J, Hu Y, Zhou X, et al
    Histologic validation of stress cardiac magnetic resonance T1-mapping techniques for detection of coronary microvascular dysfunction in rabbits.
    Int J Cardiol. 2022;347:76-82.
    >> Share

  281. GUECKEL J, Puelacher C, Glarner N, Gualandro DM, et al
    Patient- and procedure-related factors in the pathophysiology of perioperative myocardial infarction/injury.
    Int J Cardiol. 2022 Jan 11. pii: S0167-5273(22)00062.
    >> Share

  282. WU Z, Cheng S, Wang S, Li W, et al
    C-MYC ameliorates ventricular remodeling of myocardial infarction rats via binding to the promoter of microRNA-29a-3p to facilitate TET2 expression.
    Int J Cardiol. 2022 Jan 8. pii: S0167-5273(22)00067.
    >> Share

  283. HU M, Lu Y, Wan S, Li B, et al
    Long-term outcomes in inferior ST-segment elevation myocardial infarction patients with right ventricular myocardial infarction.
    Int J Cardiol. 2022 Jan 5. pii: S0167-5273(22)00003.
    >> Share

  284. GIBSON CM, Mehta S, Ceschim MRS, Frauenfelder A, et al
    Evolution of single-lead ECG for STEMI detection using a deep learning approach.
    Int J Cardiol. 2022;346:47-52.
    >> Share

  285. FERRANNINI E, Marx N, Andreini D, Campi B, et al
    Mannose as a biomarker of coronary artery disease: Angiographic evidence and clinical significance.
    Int J Cardiol. 2022;346:86-92.
    >> Share

  286. GATTO L, Alfonso F, Paoletti G, Burzotta F, et al
    Relationship betweeen the amount and location of macrophages and clinical outcome: subanalysis of the CLIMA-study.
    Int J Cardiol. 2022;346:8-12.
    >> Share

    December 2021
  287. KUCHARSKA-NEWTON AM, Loop MS, Bullo M, Moore C, et al
    Use of troponins in the classification of myocardial infarction from electronic health records. The Atherosclerosis Risk in Communities (ARIC) Study.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02014.
    >> Share

  288. DE LUCA L, Cicala SD, D'Errigo P, Cerza F, et al
    Impact of age, gender and heart failure on mortality trends after acute myocardial infarction in Italy.
    Int J Cardiol. 2021 Dec 16. pii: S0167-5273(21)02015.
    >> Share

  289. ZEITZ C
    Relieving angina - interplay between gender, pathophysiology and medication efficacy.
    Int J Cardiol. 2021;345:20-21.
    >> Share

  290. CESARO A, Gragnano F, Calabro P, Moscarella E, et al
    Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.
    Int J Cardiol. 2021;345:7-13.
    >> Share

  291. TAKAHASHI J, Shimokawa H, Yasuda S
    Usefulness of hybrid assessment for coronary functional abnormalities by non-invasive and invasive techniques.
    Int J Cardiol. 2021;345:24-25.
    >> Share

  292. GALLI M, Franchi F
    Guided selection of antiplatelet therapy in acute coronary syndrome: Impact on outcomes and resource utilization.
    Int J Cardiol. 2021;345:36-38.
    >> Share

  293. AHN JH, Ahn Y, Jeong MH, Kim JH, et al
    Optimal low-density lipoprotein cholesterol target level in Korean acute myocardial infarction patients (<70mg/dL vs. <55mg/dL): Based on Korea acute myocardial infarction registry-National Institute of Health.
    Int J Cardiol. 2021 Dec 15. pii: S0167-5273(21)02012.
    >> Share

  294. MEHTA PK, Quesada O, Al-Badri A, Fleg J, et al
    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.
    Int J Cardiol. 2021 Dec 10. pii: S0167-5273(21)02005.
    >> Share

  295. YANDRAPALLI S, Malik AH, Namrata F, Pemmasani G, et al
    Influence of diabetes mellitus interactions with cardiovascular risk factors on post-myocardial infarction heart failure hospitalizations.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01976.
    >> Share

  296. ANANTHAKRISHNA R, Liang Z, Raman B, Moran JL, et al
    Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01979.
    >> Share

  297. LEMESLE G, Bauters C, Bonello L, Fauchier L, et al
    Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillation.
    Int J Cardiol. 2021 Dec 2. pii: S0167-5273(21)01966.
    >> Share

  298. TSUJITA K
    Realistic detection of natural history of early coronary atherosclerosis: Best part of computed tomography-derived fractional flow reserve?
    Int J Cardiol. 2021;344:34-35.
    >> Share

  299. BERNTORP K, Persson J, Koul SM, Patel MR, et al
    Instantaneous wave-free ratio compared with fractional flow reserve in PCI: A cost-minimization analysis.
    Int J Cardiol. 2021;344:54-59.
    >> Share

  300. RIJLAARSDAM-HERMSEN D, van Domburg RT, Deckers JW, Kuijpers D, et al
    Comparison of guidelines for diagnosing suspected stable angina and the additional value of the calcium score.
    Int J Cardiol. 2021;344:1-7.
    >> Share

    November 2021
  301. TANG Y, Liu S, Shi Y, He T, et al
    Association of blood pressure in the first-week of hospitalization and long-term mortality in patients with acute left ventricular myocardial infarction.
    Int J Cardiol. 2021 Nov 24. pii: S0167-5273(21)01861.
    >> Share

  302. MARCOS-GARCES V, Perez N, Gavara J, Lopez-Lereu MP, et al
    Risk score for early risk prediction by cardiac magnetic resonance after acute myocardial infarction.
    Int J Cardiol. 2021 Nov 23. pii: S0167-5273(21)01866.
    >> Share

  303. GORIKI Y, Yoshioka G, Natsuaki M, Shinzato K, et al
    Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 18. pii: S0167-5273(21)01862.
    >> Share

  304. HENG GE
    Is diastolic dysfunction a new windsock in the risk stratification of patients with coronary heart disease?
    Int J Cardiol. 2021 Nov 17. pii: S0167-5273(21)01853.
    >> Share

  305. DESEIVE S, Orban M
    Choosing the right potent P2Y12-receptor inhibitor in East Asians with acute myocardial infarction and percutaneous coronary intervention - Editorial on Ticagrelor versus Prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Nov 16. pii: S0167-5273(21)01848.
    >> Share

  306. TANG LH, Harrison A, Skou ST, Doherty P, et al
    To what extent are comorbidity profiles associated with referral and uptake to cardiac rehabilitation.
    Int J Cardiol. 2021;343:85-91.
    >> Share

  307. DIXON LK, Di Tommaso E, Dimagli A, Sinha S, et al
    Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis.
    Int J Cardiol. 2021;343:27-34.
    >> Share

  308. PYXARAS SA, Harmel EK
    Artificial intelligence for the assessment of coronary artery disease- The dawn of a new era?
    Int J Cardiol. 2021;343:3-4.
    >> Share

  309. FENDER AC, Dobrev D
    Nitric oxide as a fragile switch between cardioprotection and cardiac injury.
    Int J Cardiol. 2021;343:102-103.
    >> Share

  310. NAKAJIMA A, Subban V, Russo M, Bryniarski KL, et al
    Coronary plaque and clinical characteristics of South Asian (Indian) patients with acute coronary syndromes: An optical coherence tomography study.
    Int J Cardiol. 2021;343:171-179.
    >> Share

  311. TSUGU T, Tanaka K, Belsack D, Devos H, et al
    Impact of vascular morphology and plaque characteristics on computed tomography derived fractional flow reserve in early stage coronary artery disease.
    Int J Cardiol. 2021;343:187-193.
    >> Share

  312. JENSCH PJ, Stiermaier T, Reinstadler SJ, Feistritzer HJ, et al
    Prognostic relevance of peri-infarct zone measured by cardiovascular magnetic resonance in patients with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Nov 10. pii: S0167-5273(21)01785.
    >> Share

  313. BANG C, Lauridsen KG, Andersen CF, Lofgren B, et al
    Reply to the Letter to the Editor: "Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?"
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01761.
    >> Share

  314. SOFI F, Dinu M, Reboldi G, Stracci F, et al
    Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Nov 2. pii: S0167-5273(21)01765.
    >> Share

  315. XU JJ, Cui J, Lin Q, Chen XY, et al
    Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury.
    Int J Cardiol. 2021;342:82-93.
    >> Share

  316. TRAVERSE JH
    The coronary sinus reducer - Where modern technology meets old school physiology!
    Int J Cardiol. 2021;342:31-32.
    >> Share

  317. COOK CM, Howard JP, Ahmad Y, Shun-Shin MJ, et al
    Comparing invasive hemodynamic responses in adenosine hyperemia versus physical exercise stress in chronic coronary syndromes.
    Int J Cardiol. 2021;342:7-14.
    >> Share

  318. LI KS, Bai Y, Li J, Li SL, et al
    LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway.
    Int J Cardiol. 2021;342:72-81.
    >> Share

    October 2021
  319. HAN X, Chen Z, Wang Y, Zhang J, et al
    Prognostic significance of QRS distortion and frontal QRS-T angle in patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2021 Oct 26. pii: S0167-5273(21)01693.
    >> Share

  320. BOUISSET F, Deney A, Ferrieres J, Panagides V, et al
    Mechanical complications in ST-elevation myocardial infarction: The impact of pre-hospital delay.
    Int J Cardiol. 2021 Oct 23. pii: S0167-5273(21)01574.
    >> Share

  321. ONO M, Kawashima H, Hara H, Mancone M, et al
    Impact of major infections on 10-year mortality after revascularization in patients with complex coronary artery disease.
    Int J Cardiol. 2021;341:9-12.
    >> Share

  322. WEBB CM, Collins P
    Medical management of anginal symptoms in women with stable angina pectoris: A systematic review of randomised controlled trials.
    Int J Cardiol. 2021;341:1-8.
    >> Share

  323. GIOVANNINI M, Koniari I, Mori F, Barni S, et al
    Kounis syndrome: Towards a new classification.
    Int J Cardiol. 2021;341:13-14.
    >> Share

  324. CHALIKIAS G, Tziakas DN
    Triggering receptor expressing on myeloid cells (TREM)-1 and acute myocardial infarction: An association vs. causality conundrum.
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01507.
    >> Share

  325. CHIANG CH, Chiang CH, Chiang CH
    Is single troponin measurement truly safe enough to rule out myocardial infarction in early presenters?
    Int J Cardiol. 2021 Oct 7. pii: S0167-5273(21)01388.
    >> Share

  326. PARK S, Kim YG, Ann SH, Park HW, et al
    Ticagrelor versus prasugrel in patients with acute myocardial infarction.
    Int J Cardiol. 2021 Oct 4. pii: S0167-5273(21)01505.
    >> Share

  327. ARCHILLETTI F, Zimarino M
    Intravascular ultrasound for in-stent restenosis: A problem well stated is half-solved.
    Int J Cardiol. 2021;340:22-23.
    >> Share

  328. GUO Y, Li Q, Xuan YT, Wu WJ, et al
    Exercise-induced late preconditioning in mice is triggered by eNOS-dependent generation of nitric oxide and activation of PKCepsilon and is mediated by increased iNOS activity.
    Int J Cardiol. 2021;340:68-78.
    >> Share

  329. YONG ASC, Pargaonkar VS, Wong CCY, Javadzdegan A, et al
    Abnormal shear stress and residence time are associated with proximal coronary atheroma in the presence of myocardial bridging.
    Int J Cardiol. 2021;340:7-13.
    >> Share

  330. SHLOFMITZ E, Torguson R, Zhang C, Mintz GS, et al
    Impact of intravascular ultrasound on Outcomes following PErcutaneous coronary interventioN for In-stent Restenosis (iOPEN-ISR study).
    Int J Cardiol. 2021;340:17-21.
    >> Share

    September 2021
  331. LENG WX, Yang YJ
    Reply to a fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
    Int J Cardiol. 2021 Sep 25. pii: S0167-5273(21)01484.
    >> Share

  332. REINDL M, Lechner I, Reinstadler SJ, Metzler B, et al
    Transient STEMI - No STEMI at all?
    Int J Cardiol. 2021;339:12-13.
    >> Share

  333. ISHIHARA T, Dohi T, Nakamura D, Kikuchi A, et al
    Impact of in-stent tissue characteristics on excimer laser coronary angioplasty prior to drug-coated balloon treatment.
    Int J Cardiol. 2021;339:28-32.
    >> Share

  334. LIU H, Bi K, Hu Y
    Targeting vimentin in coronary artery disease.
    Int J Cardiol. 2021;339:144.
    >> Share

  335. JANG WJ, Park IH, Yang JH, Chun WJ, et al
    Association between polyvascular disease and clinical outcomes in patients with cardiogenic shock: Results from the RESCUE registry.
    Int J Cardiol. 2021;339:70-74.
    >> Share

  336. ANGELINI P, Uribe C
    Where's the beef in anomalous coronary artery origin from an opposite aortic sinus?
    Int J Cardiol. 2021;339:45-46.
    >> Share

  337. ZORZI A, Brunetti G, Cardaioli F, D'Arcangelo F, et al
    Coronary artery calcium on standard chest computed tomography predicts cardiovascular events after liver transplantation.
    Int J Cardiol. 2021;339:219-224.
    >> Share

    August 2021
  338. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
    Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
    Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
    >> Share

    July 2021
  339. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
    Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
    Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016